Biohaven BHVN
NYSE BHVN
$12.87 -0.28 (-2.13%)
At close: Oct 2, 2026 · 4:00 PM EDT

Biohaven (BHVN) Invested Capital (2024 - 2026)

Updated

Biohaven (BHVN) recorded Invested Capital of $271.7 million in Q2 2026, down 30.6% from $391.66 million a year earlier and down 26.8% from the prior quarter.

Analysis

Biohaven (BHVN) Invested Capital (2024 - 2026) Analysis & Trends

For FY2025, Biohaven reported Invested Capital of $290.97 million, down 31.3% from FY2024.

  • Across earlier years, Invested Capital came in at $423.44 million in FY2024.
  • Quarterly Invested Capital has ranged from $251.11 million in Q3 2025 to $423.44 million in Q4 2024 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $371.41 million (Q1 2026), $290.97 million (Q4 2025) and $251.11 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 88.79 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 134.01 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 64.89 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 95.89 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 79.44 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 50.26 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 68.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 38.08 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 148.69 Bn
10 Biohaven 1.94 Bn 748.56 Mn - 271.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 271.70 Mn
Mar 31, 2026 371.41 Mn
Dec 31, 2025 290.97 Mn
Sep 30, 2025 251.11 Mn
Jun 30, 2025 391.66 Mn
Dec 31, 2024 423.44 Mn
API Access

Biohaven Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=BHVN&period=max&api_key=YOUR_API_KEY